MibampatorAlternative Names: LY-451395
Latest Information Update: 25 Oct 2011
At a glance
- Originator Eli Lilly
- Class Antidementias; Biphenyl compounds; Neuroprotectants; Small molecules; Sulfonamides
- Mechanism of Action AMPA receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Aggression; Agitation
Most Recent Events
- 16 Mar 2009 Eli Lilly initiates enrolment in a phase II trial for Alzheimer's disease in USA